Knockdown of CRNDE enhances chemosensitivity to TMZ, inhibits cell viability, decreases cell proliferation, facilitates cell apoptosis, and reduces the expression of ABCG2 in glioma cells. The gene discussed is ABCG2; the disease is glioma.